NASDAQ : HCAT
Health Catalyst, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 1.69 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 127.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 127.18M |
| Enterprise Value | 193.72M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 75.26M |
| Shares Outstanding | 75.26M |
| Shares Change (YoY) | +10.32% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 5.65% |
| Owned by Institutions (%) | 64.04% |
| Float | 59.27M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| Forward PS | 0.61 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 3.78 |
| P/FCF Ratio | 4.71 |
| P/OCF Ratio | 4.50 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | 16.46 |
| EV / EBIT | n/a |
| EV / FCF | 7.17 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.70 |
| Quick Ratio | 1.58 |
| Debt / Equity | 1.69 |
| Debt / EBITDA | 13.59 |
| Debt / FCF | 6.29 |
| Interest Coverage | -1.15 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -118.12% |
| Return on Assets (ROA) | -3.02% |
| Return on Invested Capital (ROIC) | -3.72% |
| Return on Capital Employed (ROCE) | -8.82% |
| Weighted Average Cost of Capital (WACC) | 10.84% |
| Revenue Per Employee | $243,538 |
| Profits Per Employee | -$220,681 |
| Employee Count | 1,200 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.15M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -49.40% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 1.72 |
| Relative Strength Index (RSI) | 46.77 |
| Average Volume (20 Days) | 384,390 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.07M |
| Short Previous Month | 2.21M |
| Short % of Shares Out | 2.75% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 4.59 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 292.25M |
| Gross Profit | 149.52M |
| Operating Income | -23.52M |
| Pretax Income | -263.67M |
| Net Income | -264.82M |
| EBITDA | 11.77M |
| EBIT | -23.52M |
| Loss Per Share | -$3.68 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 103.44M |
| Total Debt | 169.98M |
| Net Cash | -66.54M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | 100.83M |
| Book Value Per Share | 1.35 |
| Working Capital | 156.47M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 28.23M |
| Capital Expenditures | -1.21M |
| Depreciation & Amortization | 35.29M |
| Net Borrowing | -2.29M |
| Free Cash Flow | 27.02M |
| FCF Per Share | $0.36 |
Margins
| Measure | Value |
|---|
| Gross Margin | 51.16% |
| Operating Margin | -8.05% |
| Pretax Margin | -90.22% |
| Profit Margin | -90.61% |
| EBITDA Margin | 4.03% |
| EBIT Margin | -8.05% |
| FCF Margin | 9.25% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.32% |
| Shareholder Yield | n/a |
| Earnings Yield | -217.66% |
| FCF Yield | 21.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1.77 |
| Price Target Difference | 4.56% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | -9.87% |
| EPS Growth Forecast (3Y) | -10.28% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -4.4 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |